PIK3CA and gastric cancer: In our panel of gastric cancer cell lines, a correlation between the anti-proliferative effect of NVP-BKM120 and the genetic alterations including HER2 amplification, KRAS mutation, and both PIK3CA and KRAS mutation at the same time, was not found (Fig. 1A).